KAROXTA Trademark

Trademark Overview

On Monday, January 31, 2011, a trademark application was filed for KAROXTA with the United States Patent and Trademark Office. The USPTO has given the KAROXTA trademark a serial number of 85230063. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 8, 2014. This trademark is owned by Glaxo Group Limited. The KAROXTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
karoxta

General Information

Serial Number85230063
Word MarkKAROXTA
Filing DateMonday, January 31, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 8, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 4, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 8, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 8, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, February 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 6, 2014EXTENSION 5 GRANTED
Monday, January 27, 2014EXTENSION 5 FILED
Monday, January 27, 2014TEAS EXTENSION RECEIVED
Saturday, August 3, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 2, 2013EXTENSION 4 GRANTED
Tuesday, July 30, 2013EXTENSION 4 FILED
Tuesday, July 30, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 25, 2013EXTENSION 3 GRANTED
Wednesday, January 23, 2013EXTENSION 3 FILED
Wednesday, January 23, 2013TEAS EXTENSION RECEIVED
Wednesday, August 15, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 14, 2012EXTENSION 2 GRANTED
Monday, July 30, 2012EXTENSION 2 FILED
Tuesday, August 14, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 30, 2012TEAS EXTENSION RECEIVED
Friday, January 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 18, 2012EXTENSION 1 GRANTED
Wednesday, January 18, 2012EXTENSION 1 FILED
Wednesday, January 18, 2012TEAS EXTENSION RECEIVED
Tuesday, August 2, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2011PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 22, 2011ASSIGNED TO EXAMINER
Friday, February 4, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 3, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

karoxta pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological